In press
Welcome to our publication library. From here, you can access our company literature, such as brochures, posters, newsletters and feature articles. Please check back for updates to the library.
Downloads
Please select a category
To access abstracts of our published manuscripts, click the links below.
2011
Comparison of a novel fast-dissolving acetaminophen tablet formulation (FD-APAP) and standard acetaminophen tablets using gamma scintigraphy and pharmacokinetic studies
Wilson CG, Clarke CP, Starkey Y-YL, Clarke GD Drug Dev. Ind. Pharm 2011, 37(7), 747-753.
Correlation between in vitro and in vivo erosion behaviour of erodible tablets using gamma scintigraphy
Ghimire M, Hodges LA, Band J, O’Mahony, B, McInnes,FJ, Mullen AB, Stevens HNE. Eur. J. Pharm. 2011, 77 (1), 148-157.
2010
Assessing gastrointestinal motility and disintegration profilesof magnetic tablets by a novel magnetic imaging device and gamma scintigraphy
Goodman K, Hodges LA, Band, JA, Stevens HNE, Weitschies W, Wilson CGW. Eur. J. Pharm. Biopharm. 2010, 74(1)84-92.
In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets
Ghimire M, Hodges LA, Band J, O’Mahony, B, McInnes,FJ, Mullen AB, Stevens HNE J. Controlled Release 2010, 147(1), 70-75.
2009
Scintigraphic evaluation of colon targeting pectin-HPMC tablets in healthy volunteers
Hodges LA, Connolly SM, Band J, O’Mahony B, Ugurlu T, Turkoglu M, Wilson CG, Stevens HN Int. J. Pharm. 2009, 370(1-2), 144-150.
Do gastrointestinal transit parameters influence the pharmacokinetics of gefitinib?
Wilson CG, O’Mahony B, Connolly SM, Cantarini MV, Farmer MR, Dickinson PA, Smith RP, Swaisland HC Int. J. Pharm. 2009, 376(1-2), 7-12.
A pharmacoscintigraphic study of three time-delayed capsule formulations in healthy male volunteers
McConville JT, Hodges LA, Jones T, Band JP, O’Mahony B, Lindsay B, Ross AC, Florence AJ, Stanley AJ, Humphrey MJ, Wilson CG, Stevens HNE J. Pharm. Sci., 2009, 98(11), 4251-4263.
2007
Low dose lipid formulations: effects on gastric emptying and biliary secretion.
Kossena, G.A., Charman, W.N., Wilson, C.G., O’Mahony, B., Lindsay, B., Hempenstall, J.M., Davison, C.L., Crowley, P.J., Porter, C.J.H. Pharm. Res., 2007, 24(11), 2084-2096
Nasal residence of insulin containing lyophilised nasal insert formulations, using gamma scintigraphy.
McInnes FJ, O’Mahony B, Lindsay B, Band J, Wilson CG, Hodges LA, Stevens HN. Eur J Pharm Sci. 2007 May; 31(1):25-31.
A novel method to radiolabel gastric retentive formulations for gamma scintigraphy assessment.
Burke, M.D., Staton, J.S., Vickers, A.W., Peters, E.E., Coffin, M.D. Pharm. Res., 2007, 24(4), 695-704
2006
Behaviour and transit of tamsulosin Oral Controlled Absorption System in the gastrointestinal tract.
Stevens HN, Speakman M. Curr Med Res Opin. 2006 Dec; 22(12):2323-8.
2003
Comparison of the rates of disintegration, gastric emptying, and drug absorption following administration of a new and a conventional paracetamol formulation, using gamma scintigraphy.
Kelly K, O’Mahony B, Lindsay B, Jones T, Grattan TJ, Rostami-Hodjegan A, Stevens HN, Wilson CG. Pharm Res. 2003 Oct; 20(10):1668-73.
2002
Evaluation of Pulsincap to provide regional drug delivery of dofetilide to the human GI tractStevens, H.N.E., Wilson, C.G., Welling, P., Bakhshaee, M., Binns, J.S., Perkins, A.C., Frier, M., Blackshaw, E.P., Frame, M.W., Nichols, D.J., Humphrey, M.J., Wicks, S.R. Int. J. Pharm., 2002, 236, 27-34
Earlier
Evaluation of a gastroresistant pulsed release delivery system (Pulsincap) in humans.
Wilson, C.G., Bakhshaee, M., Stevens, H.N.E., Perkins, A., Frier, M., Blackshaw, E.P., Binns, J.S. Drug Delivery, 1997, 4, 201-206
